Hims & Hers: What’s Next for the Telehealth Trailblazer? (NYSE: HIMS) If you’ve been watching the digital health space, you know Hims & Hers isn’t just another telemedicine company—they’re rewriting the rules of how we access care. From their cheeky subway ads to their impressive subscriber growth, Hims & Hers has captured the zeitgeist of a generation that wants healthcare to be as easy as ordering takeout. But with health tech evolving at breakneck speed, what’s next for this trailblazer? Let’s look at where Hims & Hers is today—and where they’re headed tomorrow. Riding the Wave: Hims & Hers in 2025 Right now, Hims & Hers (NYSE: HIMS) is riding high, even as the stock has seen its share of volatility in recent months. Subscriber numbers and revenue are still growing, and the company is rapidly expanding beyond its roots. While they first made a splash with hair loss and ED treatments, today’s Hims & Hers is a full-fledged health platform: mental...
Packed with practical advice on investments and wealth-building strategies, we’re here to help you succeed financially. Let's get rich together!